Using Skin Biopsy Technology, CND Life Sciences Performs the 50,000th Syn-One Test(R) for Patients

Launched in 2019, the Syn-One Test is used by neurologists and other clinicians in all 50 states to aid in the diagnosis of synucleinopathies SCOTTSDALE, Ariz., /PRNewswire/ -- CND Life Sciences (CND) ...

Illumina and Grail Veterans Launch Hepta With First Liquid Biopsy-Native AI That Detects Liver Disease With Tissue-Level Biological Insights

Hepta, a biotechnology company using transformer-based AI to read the cell-free DNA (cfDNA) epigenome and detect ...